Phospho-indoles as HIV inhibitors
US8044091B2 · kind B2 · utility
1Cited by
22References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2008 |
| Grant date | Oct 25, 2011 |
| Priority date | — |
| Expiry date | Mar 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
3-phosphoindole compounds for the treatment of retroviral infections, and particularly for HIV, are described. Also included are compositions comprising the 3-phosphoindole derivatives alone or in combination with one or more other anti-retroviral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.